Evaluation of a new bladder tumor marker.
Urol Clin North Am
; 18(3): 509-13, 1991 Aug.
Article
en En
| MEDLINE
| ID: mdl-1877113
ABSTRACT
Two monoclonal antibodies have been developed that bind to a shed bladder tumor-associated antigen. Preliminary data have demonstrated that antigen-positive tumors shed detectable amounts of antigen in the urine while antigen-negative tumors do not. This antigen may be differentially metabolized by normal and malignant urothelial cells. Further characterization of this antigen and its evaluation as a urinary marker for antigen positive bladder cancers is continuing.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Vejiga Urinaria
/
Biomarcadores de Tumor
/
Antígenos de Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Urol Clin North Am
Año:
1991
Tipo del documento:
Article